A Randomized Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab in Patients with Giant Cell Arteritis

  • Gingold, Michael (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/18/CALN/614 (ERM Project ID: 49520)
NMA SSA Reference Number: SSA/49520/MonH-2019-171971(v1)
Monash Health Ref: RES-19-0000-314X
Effective start/end date20/06/1919/06/24


  • clinical trial
  • treatment efficacy
  • Giant Cell Arteritis